Status:
ACTIVE_NOT_RECRUITING
NORCCAP: Norwegian Colorectal Cancer Prevention Trial
Lead Sponsor:
Norwegian Department of Health and Social Affairs
Collaborating Sponsors:
Norwegian Cancer Society
Conditions:
Colorectal Cancer
Adenoma
Eligibility:
All Genders
50-64 years
Phase:
NA
Brief Summary
The purpose of this study is to see if screening with flexible sigmoidoscopy (a flexible viewing tube) may reduce large bowel cancer and cancer deaths. The researchers also want to see if the addition...
Detailed Description
Although flexible sigmoidoscopy (FS) as a screening tool has a much higher test sensitivity than fecal occult blood tests (FOBT) for colorectal cancer and high-risk adenomas, randomised trials with lo...
Eligibility Criteria
Inclusion
- Men and women
- Living in Oslo or Telemark
- Age 50-64 years
Exclusion
- Patients with previous open colorectal surgery (resections, enterostomies)
- Individuals in need of long lasting attention and nursing services (somatic or psychosocial reasons, mental retardation)
- On-going cytotoxic treatment or radiotherapy for malignant disease
- Severe chronic cardiac or lung disease (NYHA III-IV)
- Patients with heart valve replacement on life long anticoagulant therapy
- A coronary event during the last 3 months if having lead to hospitalisation
- Cerebrovascular accident during the last 3 months
- Resident abroad
Key Trial Info
Start Date :
January 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2036
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT00119912
Start Date
January 1 1999
End Date
December 1 2036
Last Update
April 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Population-based Cancer Research
Oslo, Norway, 0310